PDF icon Download PDF
Osteosynthesis and Trauma Care 2005; 13(4): 254-260
DOI: 10.1055/s-2005-872479
Original Article

© Georg Thieme Verlag Stuttgart · New York

Bone Morphogenic Proteins: Their Role in Fracture Management

R. Miller1 , A. Shimmin2
  • 1Orthopaedic Clinic 2, Alfred Hospital, Melbourne, Victoria, Australia
  • 2Melbourne Orthopaedic Group, Melbourne, Victoria, Australia
Further Information

Publication History

Publication Date:
01 December 2005 (online)

   Permissions and Reprints
Preview

Abstract

Delayed fracture healing and non-union remain problems in fracture management. Over the last two decades improvement with fixation has assisted with the management of these problems. Bone morphogenic proteins represent a novel approach to biologically stimulate fractures to accelerate bone healing. This article overviews some of the experimental and clinical studies to support the use of this technique.

Key words

Bone morphogenic protein - delayed bone healing - fracture management

References

  • 1 Bassett C A, Mitchell S N, Gaston S R. Treatment of ununited tibial diaphyseal fractures with pulsing electromagnetic fields.  J Bone Joint Surg [Am]. 1981;  63 511-523
    PubMedSearch in Google Scholar
  • 2 Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg [Am] 2002 84: 2123-2134
    Search in Google Scholar
  • 3 Boden S D, Martin G J, Morone M A, Ugbo J L, Moskovitz P A. Posterolateral lumbar intertransverse process spine arthrodesis with recombinant human bone morphogenitic protein 2/hydroxyapatite-tricalcium phosphate after laminectomy in the nonhuman primate.  Spine. 1999;  24 1179-1185
    CrossrefPubMedSearch in Google Scholar
  • 4 Boden S D, Zdeblick T A, Sandhu H S, Helm S E. The use of rhBMP-2 in inter-body fusion cages. Definitive evidence of osteoinduction in humans; a preliminary report.  Spine. 2000;  25 376-381
    CrossrefPubMedSearch in Google Scholar
  • 5 Bogoch E R, Moran E L. Bone abnormalities in the surgical treatment of patients with rheumatoid arthritis.  Clin Orthop. 1999;  8 21
    PubMedSearch in Google Scholar
  • 6 Bonatus T, Olson S A, Lee S, Chapman M W. Nonreamed locking intramedullary nailing for open fractures of the tibia.  Clin Orthop. 1997;  339 58-64
    PubMedSearch in Google Scholar
  • 7 Boyd H B, Lipinski S W, Wiley J H. Observations on non-union of the shafts of the long bones, with a statistical analysis of 842 patients.  J Bone Joint Surg [Am]. 1961;  43 159-168
    PubMedSearch in Google Scholar
  • 8 Boyne P J, Marx R E, Nevins M, Triplett G, Lazaro E, Lilly L C, Alder M, Nummikoski P. A feasibility study evaluating rhBMP-2/absorbable collagen sponge for maxillary sinus floor augmentation.  Int J Periodontics Restorative Dent. 1997;  17 11-25
    PubMedSearch in Google Scholar
  • 9 Brighton C T, Shaman P, Heppenstall R B, Esterhai J L, Pollack S R, Friedenberg Z B. Tibial non-union treated with direct current, capacitive coupling or bone graft.  Clin Orthop. 1995;  321 223-234
    PubMedSearch in Google Scholar
  • 10 Carter D R, Blenman P R, Beaupre G S. Correlations between mechanical stress history and tissue differentiation in initial fracture healing.  J Orthop Res. 1988;  6 736-748
    CrossrefPubMedSearch in Google Scholar
  • 11 Caudle R J, Stern P J. Severe open fractures of the tibia.  J Bone Joint Surg [Am]. 1987;  69 801-807
    PubMedSearch in Google Scholar
  • 12 Chen X, Kidder L S, Lew W D. Osteogenic protein-1 induced bone formation in an infected segmental defect in the rat femur.  J Orthop Res. 2002;  20 142-150
    CrossrefPubMedSearch in Google Scholar
  • 13 Cook S D, Baffes G C, Wolfe M W, Sampath T K, Rueger D C. Recombinant human bone morphogenic proten-7 induces healing in a canine long bone segmental defect model.  Clin Orthop. 1994;  30 302-312
    PubMedSearch in Google Scholar
  • 14 Cook S D, Baffes G C, Wolfe M W, Sampath T K, Rueger D C, Whitecloud T S. Effect of recombinant human osteogenic protein-l on healing of large segmental bone defects.  J Bone Joint Surg [Am]. 1994;  76 827-838
    PubMedSearch in Google Scholar
  • 15 Cook S D, Salkeld S L, Brinker M R, Wolfe M W, Rueger D C. Use of an osteoinductive biomaterial (rhOP-1) in healing large segmental bone defects.  J Orthop Trauma. 1998;  12 407-412
    CrossrefPubMedSearch in Google Scholar
  • 16 Cook S D, Wolfe M W, Salkeld S L, Rueger D C. Recombinant human osteogenic protein-1 (rhOP-1) heals segmental defects in nonhuman primates.  J Bone Joint Surg [Am]. 1995;  77 734-750
    PubMedSearch in Google Scholar
  • 17 Day S M, Ostrum R F, Chao E YS, Rubin C T, Aro H T, Einhorn T A. Bone injury, regeneration and repair. In: Buckwalter JA, Einhorn TA, Simon SR (eds). Orthopaedic basis science - biology and biomechanical of the musculoskeletal system. American Academy of Orthopaedic Surgeons, Rosemont, IL 2000; 371
  • 18 Einhorn T A, Levine B, Michel P. Nutrition and bone.  Orthop Clin North Am. 1990;  21 4350
    PubMedSearch in Google Scholar
  • 19 Fischgrund J S, James S B, Chabot M C, Hankin R, Herkowitz H N, Wozney J M, Shirkhoda A. Augmentation of autograft using rhBMP-2 and different carrier media in the canine spinal fusion model.  J Spinal Disord. 1997;  10 467-472
    PubMedSearch in Google Scholar
  • 20 Friedlaender G E, Perry C R, Cole D, Cook S D, Ciemy G, Muschler G F, Zych G A, Calhoun J H, LaForte, Yin S. Osteogenic protein-1 (bone morphogenic protein-7) in the treatment of tibial non-unions.  J Bone Joint Surg [Am]. 2001;  83 (suppl I, part 2) 151-158
    PubMedSearch in Google Scholar
  • 21 Geesink R GT, Hoefnagels N HM, Bulstra S K. Osteogenic activity of OP-1 bone morphogenic protein (BMP-7) in a human fibular defect.  J Bone Joint Surg [Br]. 1999;  81 710-718
    PubMedSearch in Google Scholar
  • 22 Heppenstall R B, Brighton C T, Esterhai J R, Muller G. Prognosis factors in non-unions of the tibia; an evaluation of 185 cases treated with constant direct current.  J Trauma. 1984;  24 790-795
    PubMedSearch in Google Scholar
  • 23 Kwiatowski T C, Hanley E N, Ramp W K. Cigarette smoking and its orthopaedic consequences.  Am J Orthop. 1996;  25 590-597
    PubMedSearch in Google Scholar
  • 24 Kyro A, Usenius J P, Aamio M, Kunnamo I, Avikainen V. Are smokers a risk group for delayed healing of tibial shaft fractures?.  Ann Chir Gynaecol. 1993;  82 254-262
    PubMedSearch in Google Scholar
  • 25 Mayr E, Frankel V, Ruter A. Ultrasound - an alternative healing method for nonunions?.  Arch Orthop Trauma Surg. 2000;  120 1-8
    PubMedSearch in Google Scholar
  • 26 Patel T C, Erulkar J S, Grauer I N, Troiano N W, Panjabi M M, Friedlaender G E. Osteogenic protein-1 overcomes the inhibitory effect of nicotine on posterolateral lumbar fusion.  Spine. 2001;  25 1656-1661
    PubMedSearch in Google Scholar
  • 27 Perren S M. Physical and biological aspects of fracture healing with special reference to internal fixation.  Clin Orthop. 1979;  138 175-196
    PubMedSearch in Google Scholar
  • 28 Praemer A, Furner S, Rice D P. Musculoskeletal conditions in the United States. The American Academy of Orthopaedic Surgeons, Park Ridge, IL, 1992; 83
  • 29 Riemer B L, DiChristina D G, Cooper A, Sagiv S, Butterfield S L, Burke C J, Lucke J F, Schlosser J D. Nonreamed nailing of tibial diaphyseal fractures in blunt polytrauma patients.  J Orthop Trauma. 1995;  9 66-75
    PubMedSearch in Google Scholar
  • 30 Ryaby J T. Clinical effects of electromagnetic and electric fields on fracture healing.  Clin Orthop. 1998;  355 (Suppl) 205-215
    PubMedSearch in Google Scholar
  • 31 Sampath T K, Ozkaynak E, Jones E, Sasa H, Tucker R, Tucker M. et al . Recombinant human osteogenic protein-1 (hOP-1) induces new bone formation in vivo with a specific activity comparable with natural bovine osteogenic protein and stimulates osteoblast proliferation and differentiation in vitro.  J Biol Chem. 1992;  267 352-362
    PubMedSearch in Google Scholar
  • 32 Sanders R, Jersinovich I, Anglen J, DiPasquale T, Herscovici D. The treatment of open tibial shaft fractures using an interlocked intramedullary nail without reaming.  J Orthop Trauma. 1994;  8 501-510
    PubMedSearch in Google Scholar
  • 33 Shimmin A, Ruff S. Clinical use of recombinant human osteogenic protein-1 (rhOP-1).  Bone. 1999;  24 409-431
    PubMedSearch in Google Scholar

Dr. Russell MillerFRAC 

Orthopaedic Clinic 2 · Alfred Hospital

Commercial Road

P.O. Box 315

Prahran, Victoria 3181

Australia

Fax: +61/3/92 76 22 22

Email: rmiller3@bigpond.net.au